Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA for Inflammation-Related Anhedonia in Depression
NCT04723147Phase 4Completed
- Sponsor
- Emory University
- Start
- Jan 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in major depressive disorder (MDD), anhedonia ((none)), sponsored by Emory University. Started Jan 2021; status: completed.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)anhedonia ((none))
Beyond the preview
Go deeper on NCT04723147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04723147.